Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Acute Disseminated Encephalomyelitis

What is Acute Disseminated Encephalomyelitis ?

Acute disseminated encephalomyelitis (ADEM) is a rare disease caused by inflammation in the brain and spinal cord that breaks down myelin and damages nerve cells and nerve impulses. To elaborate, acute refers to the rapid onset, disseminated means to spread through an organ in the body, and encephalomyelitis is the destruction of myelin surrounding nerve cells in the brain. 

Myelin is a protective coating found on the axons of nerve cells that helps electrical signals travel down the length of the nerve cell and deliver messages (in the form of neurotransmitters) to the next nerve cell. Swelling and inflammation occur when the immune system detects something that is foreign to the body and wants to protect against it. This can be something like bacteria or viruses, or in rare cases, a vaccine. It can also be an autoimmune reaction, when the body’s immune system mistakenly attacks healthy cells and tissues. When inflammation occurs in the brain and breaks down myelin tissue, it can affect the functions that rely on nerve signals such as vision, muscle movement, walking, and consciousness. Acute disseminated encephalomyelitis is more common in children than adults, and about 50% of cases occur 4-14 days following an infection with symptoms such as fever, headache, nausea and vomiting, and possible seizures.

 

 

Synonyms

  • Acute disseminated encephalomyelitis
  • Post-infection encephalomyelitis
  • Immune-mediated encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare disease caused by inflammation in the brain and spinal cord that breaks down myelin and damages nerve cells and nerve impulses. To elaborate, acute refers to the rapid onset, disseminated means to spread through an organ in the body, and encephalomyelitis is the destruction of myelin surrounding nerve cells in the brain. 

Myelin is a protective coating found on the axons of nerve cells that helps electrical signals travel down the length of the nerve cell and deliver messages (in the form of neurotransmitters) to the next nerve cell. Swelling and inflammation occur when the immune system detects something that is foreign to the body and wants to protect against it. This can be something like bacteria or viruses, or in rare cases, a vaccine. It can also be an autoimmune reaction, when the body’s immune system mistakenly attacks healthy cells and tissues. When inflammation occurs in the brain and breaks down myelin tissue, it can affect the functions that rely on nerve signals such as vision, muscle movement, walking, and consciousness. Acute disseminated encephalomyelitis is more common in children than adults, and about 50% of cases occur 4-14 days following an infection with symptoms such as fever, headache, nausea and vomiting, and possible seizures.

 

Acknowledgement of Acute Disseminated Encephalomyelitis has not been added yet.

Acute disseminated encephalomyelitis (ADEM) is a rare disease estimated to affect about 1 in 125,000-250,000 people every year. Of these diagnosed cases, about 50-60% are due to a prior infection and 40-50% are likely autoimmune in origin. Less than 5% of cases due to infection may have been caused by an inflammatory response to a vaccine. 

Children are more likely to be diagnosed with ADEM than adults, with 80% of cases diagnosed in children under 10 years and the remaining 20% of cases diagnosed between the ages of 10-20 years. It is also more common in children assigned male at birth, about 60% of cases compared to 40% of diagnosed cases in children assigned female at birth. ADEM is commonly diagnosed in the winter and spring, which could be due to higher cases of infection during this time period.

 

Name Abbreviation
ADEM
ADEM
ADEM
ADEM
ADEM
ADEM
Acute disseminated encephalomyelitis ADEM
Post-infection encephalomyelitis PIEM
Immune-mediated encephalomyelitis IMEM

Acute disseminated encephalomyelitis (ADEM) is caused by swelling and inflammation in regions of the brain that damages myelin surrounding nerve cell axons. This swelling and inflammatory response can be due to an infection or an autoimmune response. About half of all diagnosed cases are associated with an infection, which can cause symptoms to develop within 4-14 days, and the other half of diagnosed cases are classified as autoimmune. Post-infection cases are caused by bacterial or viral infections that occur in children and cause their antibodies to wreak havoc on their immune system. In very rare cases, a vaccination may cause this inflammatory response and ADEM to occur. Autoimmune cases are likely caused by a particular type of auto-antibody directed against myelin oligodendrocyte glycoprotein (MOG). These auto-antibodies target the myelin sheath around nerve cells and break it down, and they have been detected in about 36-64% of children who were diagnosed with ADEM.

The symptoms of acute disseminated encephalomyelitis (ADEM) are indicative of both an infection and subsequent nerve damage. Early signs of ADEM indicate that an inflammatory response has occurred:

  • Fever and sickness

  • Headache

  • Nausea and vomiting

  • Seizures

After inflammation has caused damage to the myelin in the brain (demyelination), certain signaling pathways are affected. These can affect motor functions and other bodily functions, causing the following symptoms:

  • Muscle weakness, especially in the arms and legs

  • Numbness or tingling sensation

  • Loss of vision

Acute disseminated encephalomyelitis (ADEM) is a rare disease with similar symptoms to other demyelinating disorders (those that damage myelin in the brain). This includes multiple sclerosis, a chronic disease causing damage to myelin to take place over time and cause increasing damage to bodily functions. To distinguish between ADEM and MS, there are a few characteristics of each disease that help with an initial diagnostic pathway:

Distinguishing Feature

ADEM

MS

Occurrence

One occurrence of myelin damage in a lifetime

Chronic damage to myelin throughout lifetime

Symptoms

Fever, headache, nausea, seizures, symptoms of nerve damage

Symptoms of nerve damage

Gender

More commonly diagnosed in children assigned male at birth

More commonly diagnosed in people assigned female at birth

Age

More common in children

More common in adults

Additional testing can aid in distinguishing a diagnosis of acute disseminated encephalomyelitis (ADEM) from other demyelinating disorders such as MS. These mainly focus on determining that damage to the myelin occurred as a single instance and was the result of antibodies and inflammation in the brain:

  1. Magnetic resonance imaging (MRI) - Imaging areas of the brain detects lesions to myelin caused by inflammation. It is important to follow up with multiple MRIs to make sure that no further damage occurs, which indicates a diagnosis of ADEM over more chronic MS.

  2. Auto-antibody testing in cerebrospinal fluid (CSF) - A lumbar puncture and extraction of cerebrospinal fluid (CSF) allows for the analysis of immune cells present that could potentially be causing inflammation of the brain. The presence of myelin oligodendrocyte glycoprotein (MOG) auto-antibodies is especially indicative of an ADEM diagnosis.

Acute disseminated encephalomyelitis (ADEM) is a rare disease with no known cure, and treatments focus on reducing inflammation and preventing future incidences of myelin damage. To this end, the following have been shown to improve symptoms of ADEM:

  1. Corticosteroids - Drugs such as methyl-prednisolone (Solu-Medrol) aim at immune-suppression and reducing inflammation. 

  2. Plasma exchange (plasmapheresis) - The removal of one’s immune cells that may be causing an autoimmune response can improve symptoms of ADEM. This is accomplished by circulating blood from the body through a machine that separates out components from the immune system and then returns the blood to circulation.

  3. Immunoglobulin therapy - Immunoglobulin is an antibody that specifically targets immune cells and destroys them. Injections of immunoglobulin can help reduce auto-antibodies in the blood and prevent further inflammation.

Acute disseminated encephalomyelitis often presents as a one-time occurrence of inflammation in the central nervous system. If the damage to myelin sheaths surrounding nerve cells is not extensive, and if the inflammation can be prevented from happening again, children with ADEM often recover and lead healthy lives. For most children diagnosed with ADEM who receive treatment, they begin to recover within days. Some will have lasting effects of nerve damage such as blurred vision, weakness or numbness, or lower muscle movement.

 

Tips or Suggestions of Acute Disseminated Encephalomyelitis has not been added yet.
new to the community Created by michjen
Last updated 24 Oct 2014, 07:45 PM

Posted by michjen
24 Oct 2014, 07:45 PM

Hello, I am mother to a 5 year old boy who was diagnosed with ADEM 2 months ago. I joined Rareshare to connect with other caregivers and individuals affected by this rare disorder. My son is currently doing inpatient rehab, and has gradually regained strength in his left arm and leg. We are hoping to have him back home again in mid-November. We have a follow-up appointment with his neurologist on Monday. Does anyone have any suggestions on what to ask during our follow-up visit?

Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

Beau was diagnosed in 1996 with inability to balance, walk, talk, etc. Has been hospitalized several times. Two steps forward, one step backwards.
mother of a 5 year old boy with ADEM
Still searching
My only son, Josh seemed healthy until he was 8 and a half years old, when he suddenly collapsed and went into respiratory failure. He was diagnosed later with ROHHAD. There is a documentary about...

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

new to the community

Created by michjen | Last updated 24 Oct 2014, 07:45 PM


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.